{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-035644","form_type":"8-K","ticker":"OTLK","cik":"0001649989","company_name":"Outlook Therapeutics, Inc.","filed_at":"2024-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.977117+00:00","generated_at":"2026-06-04T15:15:51.313480+00:00","sec_items":["3.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Outlook Therapeutics closes $60M private placement and effects 1-for-20 reverse stock split","bullets":["Private placement raised ~$60M via 8.57M shares at $7.00 each plus warrants for 12.86M shares at $7.70.","Warrants expire March 18, 2029; exercise price $7.70 per share.","1-for-20 reverse stock split effective March 13, 2024; authorized shares reduced to 60M.","After split and before placement, ~13.0M shares outstanding; securities sold under Rule 506 exemption."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-035644","json":"https://secwatch.observer/filing/0001104659-24-035644.json","markdown":"https://secwatch.observer/filing/0001104659-24-035644.md","text":"https://secwatch.observer/filing/0001104659-24-035644.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649989/000110465924035644/0001104659-24-035644-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649989/000110465924035644/tm249047d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T15:15:51.313480+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7e3f30c45fab12e44f6b4c13699251211feb72ee","claim":"Outlook Therapeutics, Inc.: Effected a 1-for-20 reverse stock split and proportionate reduction in authorized shares of Common Stock via Certificate of Amendment to the Amended and Restated Certificate of Incorporation (effective 2024-03-13).","evidence_excerpt":"Effective March 13, 2024 at 5:00 p.m. Eastern Time, the Company effected a 1-for-20 reverse stock split and proportionate reduction in the number of authorized shares of Common Stock pursuant to a Certificate of Amendment of the Amended and Restated Certificate of Incorporation","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1649989/000110465924035644/0001104659-24-035644-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-03-13"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}